Capital Investment Counsel LLC raised its position in shares of JPMorgan Chase & Co. (NYSE:JPM – Free Report) by 1.8% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 37,417 shares of the financial services provider’s stock after buying an additional 657 shares during the quarter. JPMorgan Chase & Co. accounts for 1.4% of Capital Investment Counsel LLC’s portfolio, making the stock its 23rd largest position. Capital Investment Counsel LLC’s holdings in JPMorgan Chase & Co. were worth $7,890,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds also recently bought and sold shares of the company. Dimensional Fund Advisors LP increased its holdings in JPMorgan Chase & Co. by 4.8% in the second quarter. Dimensional Fund Advisors LP now owns 22,696,963 shares of the financial services provider’s stock worth $4,590,412,000 after buying an additional 1,040,594 shares during the last quarter. International Assets Investment Management LLC acquired a new position in JPMorgan Chase & Co. in the third quarter worth approximately $1,888,088,000. Envestnet Asset Management Inc. boosted its position in JPMorgan Chase & Co. by 2.2% during the second quarter. Envestnet Asset Management Inc. now owns 7,286,705 shares of the financial services provider’s stock worth $1,473,809,000 after purchasing an additional 157,577 shares during the period. Sumitomo Mitsui Trust Group Inc. boosted its position in JPMorgan Chase & Co. by 3.9% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 7,017,646 shares of the financial services provider’s stock worth $1,479,741,000 after purchasing an additional 261,363 shares during the period. Finally, Principal Financial Group Inc. boosted its position in JPMorgan Chase & Co. by 3.2% during the third quarter. Principal Financial Group Inc. now owns 5,824,289 shares of the financial services provider’s stock worth $1,228,110,000 after purchasing an additional 182,648 shares during the period. 71.55% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
JPM has been the subject of a number of recent analyst reports. Daiwa Capital Markets decreased their target price on JPMorgan Chase & Co. from $240.00 to $235.00 and set an “overweight” rating for the company in a research report on Thursday, October 10th. Barclays upped their target price on JPMorgan Chase & Co. from $217.00 to $257.00 and gave the stock an “overweight” rating in a research report on Monday, October 14th. Oppenheimer cut JPMorgan Chase & Co. from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 20th. Evercore ISI increased their price objective on JPMorgan Chase & Co. from $217.00 to $230.00 and gave the company an “outperform” rating in a research report on Monday, October 14th. Finally, Morgan Stanley cut JPMorgan Chase & Co. from an “overweight” rating to an “equal weight” rating and increased their price objective for the company from $220.00 to $224.00 in a research report on Monday, September 30th. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $229.31.
JPMorgan Chase & Co. Stock Down 0.1 %
JPM opened at $249.75 on Thursday. The firm has a market cap of $703.13 billion, a price-to-earnings ratio of 13.90, a PEG ratio of 3.63 and a beta of 1.10. The company has a debt-to-equity ratio of 1.27, a quick ratio of 0.89 and a current ratio of 0.89. The firm’s 50-day simple moving average is $225.64 and its 200-day simple moving average is $213.00. JPMorgan Chase & Co. has a twelve month low of $152.72 and a twelve month high of $254.31.
JPMorgan Chase & Co. (NYSE:JPM – Get Free Report) last issued its quarterly earnings data on Friday, October 11th. The financial services provider reported $4.37 earnings per share for the quarter, topping the consensus estimate of $4.02 by $0.35. The firm had revenue of $43.32 billion for the quarter, compared to analysts’ expectations of $41.43 billion. JPMorgan Chase & Co. had a net margin of 19.64% and a return on equity of 16.71%. The company’s quarterly revenue was up 6.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $4.33 earnings per share. Equities research analysts anticipate that JPMorgan Chase & Co. will post 17.62 EPS for the current fiscal year.
JPMorgan Chase & Co. Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 31st. Stockholders of record on Friday, October 4th were issued a dividend of $1.25 per share. This is a positive change from JPMorgan Chase & Co.’s previous quarterly dividend of $1.15. The ex-dividend date of this dividend was Friday, October 4th. This represents a $5.00 annualized dividend and a dividend yield of 2.00%. JPMorgan Chase & Co.’s dividend payout ratio (DPR) is presently 27.82%.
JPMorgan Chase & Co. Profile
JPMorgan Chase & Co operates as a financial services company worldwide. It operates through four segments: Consumer & Community Banking (CCB), Corporate & Investment Bank (CIB), Commercial Banking (CB), and Asset & Wealth Management (AWM). The CCB segment offers deposit, investment and lending products, cash management, and payments and services; mortgage origination and servicing activities; residential mortgages and home equity loans; and credit cards, auto loans, leases, and travel services to consumers and small businesses through bank branches, ATMs, and digital and telephone banking.
Recommended Stories
- Five stocks we like better than JPMorgan Chase & Co.
- What is a buyback in stocks? A comprehensive guide for investors
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Best Stocks Under $5.00
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Top Stocks Investing in 5G Technology
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for JPMorgan Chase & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan Chase & Co. and related companies with MarketBeat.com's FREE daily email newsletter.